Bayer’s net loss deepens on litigation costs; sees flat earnings, sales in 2026

Bayer reported a deepening net loss due to litigation costs and forecasts flat earnings and sales for 2026. Although Q4 EBITDA declined year-over-year, it still beat analyst estimates.